Why Coffee and Green Tea Behave Differently in the Same Cup: The L-Theanine and Caffeine Question

Why Coffee and Green Tea Behave Differently in the Same Cup: The L-Theanine and Caffeine Question

Reading time: 6 minutes · Category: Ingredient Science

Most people who drink coffee know the feeling that arrives about forty minutes in. Alertness, yes — but often a jittery edge underneath it, a slight tightening that makes focused work harder rather than easier. Green tea contains caffeine too, sometimes a meaningful amount, yet it rarely produces the same edge. For a long time this was treated as folklore. Over the past two decades it has become one of the more carefully studied questions in nootropic research, and the answer sits with a single amino acid: L-theanine.

What L-theanine actually is

L-theanine is a non-protein amino acid found almost exclusively in the tea plant, Camellia sinensis. Structurally it resembles glutamate, one of the brain's primary signalling molecules, and researchers investigating its mechanism have described a partial interaction with the same receptor systems glutamate uses. That structural resemblance is the starting point for why it is studied at all — it is close enough to an active neurotransmitter to be worth examining, and different enough not to behave identically.

It is worth being precise here about what that means. A mechanism is a description of how a molecule interacts with the body. It is not a promise of an outcome. Much of the confusion around nootropics comes from collapsing those two things together, and the research literature is careful to keep them apart even when the popular writing is not.

The combination that keeps appearing in the data

The interesting studies are not the ones examining L-theanine alone. They are the ones examining L-theanine alongside caffeine, because the two appear to modify each other.

A meta-analysis pooling ten acute randomised controlled trials in healthy adults reported that the combination was associated with improvements in alertness and attention-switching accuracy. The authors were candid that a large share of the attention effect was attributable to caffeine itself — L-theanine's contribution appeared to be in shaping how that caffeine effect expressed itself, rather than driving the alertness independently.

Doses across this literature cluster in a recognisable range. Trials frequently pair roughly 100 to 200 mg of L-theanine with 40 to 160 mg of caffeine — proportions not far from what a strong cup of tea delivers, which is part of why the tea comparison is more than a metaphor.

The study that reads like a field experiment

The most vivid trial in this area did not take place in a quiet testing booth. Researchers recruited thirty-seven healthy adults, kept them awake overnight, and then sat them in front of a computerised task built around traffic scenes. The participants had to respond quickly to imminent-accident situations — which appeared only twenty percent of the time — while ignoring the far more frequent safe scenes filling the other eighty percent. A thirty-two-channel EEG recorded their brain activity throughout.

The point of the design was stress-testing. Sleep deprivation reliably degrades selective attention; the researchers wanted to see whether a 200 mg L-theanine and 160 mg caffeine combination changed the neurobehavioural and neurophysiological picture in people whose attention was already compromised. It is one of the cleaner examples in the field of an ingredient being examined under conditions that resemble real life rather than laboratory calm — a night without sleep, a task demanding sustained vigilance, and a measurable electrical signature of attention being tracked in real time.

That is the kind of study worth reading in full rather than trusting a summary of, ours included. The link is below.

What this does and does not tell you

Here is the uncomfortable part, and the part most supplement writing skips. Individual promising trials are not the same as regulatory consensus. The European Food Safety Authority sets a deliberately high bar for authorised health claims, and the overwhelming majority of nootropic ingredients — including well-studied ones — do not clear it. Evidence being interesting is not the same as evidence being settled.

We think that distinction is the whole game. A brand that tells you an ingredient is proven to do something is either misreading the literature or hoping you will not check. The honest position is narrower and, we would argue, more useful: here is the molecule, here is how it appears to work mechanistically, here is the human research examining it, and here is what that research has and has not established. What you do with that is your decision to make.

The PONS position on transparency

Every PONS formula discloses each ingredient and its exact milligram dose on the label. No proprietary blends, no hidden quantities. That policy exists precisely because of everything above — if the dose is what the research is built on, then hiding the dose makes the research meaningless to you as a buyer. You cannot compare a product to a study you cannot map it onto.


This article discusses published scientific research for educational purposes. It does not constitute a health claim. Food supplements are not a substitute for a varied and balanced diet and a healthy lifestyle. PONS products are food supplements.

Referenced research: meta-analysis of L-theanine and caffeine on attention in healthy adults; double-blind placebo-controlled crossover trial of a 200 mg L-theanine / 160 mg caffeine combination on selective attention in sleep-deprived adults (available via the National Library of Medicine, PMC12491391).

Back to blog